Wen Shang Saw

Wen Shang Saw

Auto-generated profile, based on publicly available information

Wen Shang Saw

Department of Pharmacy, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
WSWen Shang Saw
Wen Shang Saw
MUMasaki Ujihara
Masaki Ujihara
WCWu Yi Chong
Wu Yi Chong
SVSiew Hui Voon
Siew Hui Voon
TIToyoko Imae
Toyoko Imae
LCLip Yong Chung
Lip Yong Chung

1 January 2022 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
SFStephanie Sally Fong
Stephanie Sally Fong
YFYiing Yee Foo
Yiing Yee Foo
WSWen Shang Saw
Wen Shang Saw
BLBey Fen Leo
Bey Fen Leo
YTYin Yin Teo
Yin Yin Teo
LKLik Voon Kiew
Lik Voon Kiew
Purpose: The use of nanocarriers to improve the delivery and efficacy of antimetastatic agents is less explored when compared to cytotoxic agents. This study reports the entrapment of an antimetastatic Signal Transducer and Activator of Transcription 3 (STAT3) dimerization blocker, Stattic (S) into a chitosan-coated-poly(lactic-co-glycolic acid) (C-PLGA) nanocarrier and the improvement on the drug’s physicochemical, in vitro and in vivo antimetastatic properties post entrapment. Methods: In vitro, physicochemical properties of the Stattic-entrapped C-PLGA nanoparticles ([email protected]) and Stattic-entrapped PLGA nanoparticles ([email protected], control) in terms of size, zeta potential, polydispersity index, drug loading, entrapment efficiency, Stattic release in different medium and cytotoxicity were firstly evaluated. The in vitro antimigration properties of the nanoparticles on breast cancer cell lines were then studied by Scratch assay and Transwell assay. Study on the in vivo antitumor efficacy and antimetastatic properties of [email protected] compared to Stattic were then performed on 4T1 tumor bearing mice. Results: The [email protected] nanoparticles (141.8 ± 2.3 nm) was hemocompatible and exhibited low Stattic release (12%) in plasma. [email protected] also exhibited enhanced in vitro anti-cell migration potency (by > 10-fold in MDA-MB-231 and 5-fold in 4T1 cells) and in vivo tumor growth suppression (by 33.6%) in 4T1 murine metastatic mammary tumor bearing mice when compared to that of the Stattic-treated group. Interestingly, the number of lung and liver metastatic foci was found to reduce by 50% and 56.6%, respectively, and the average size of the lung metastatic foci was reduced by 75.4% in 4T1 tumor-bearing mice treated with [email protected] compared to Stattic-treated group (p < 0.001). Conclusion: These findings suggest the usage of C-PLGA nanocarrier to improve the delivery and efficacy of antimetastatic agents, such as Stattic, in cancer therapy.

29 October 2017 in Journal of Nanoparticle Research
Verified
Journal Article
Closed access
PDF file
YHYu-Hsuan Hsu
Yu-Hsuan Hsu
HHHui-Ling Hsieh
Hui-Ling Hsieh
GVGeetha Viswanathan
Geetha Viswanathan
SVSiew Hui Voon
Siew Hui Voon
CKChin Siang Kue
Chin Siang Kue
LCLip Yong Chung
Lip Yong Chung

12 January 2021 in Advanced Therapeutics
Verified
Journal Article
Closed access
PDF file
WSWen Shang Saw
Wen Shang Saw
TATheebaa Anasamy
Theebaa Anasamy
YFYiing Yee Foo
Yiing Yee Foo
YKYee Chu Kwa
Yee Chu Kwa
CKChin Siang Kue
Chin Siang Kue
LCLip Yong Chung
Lip Yong Chung

24 May 2022 in Macromolecular Bioscience
Verified
Journal Article
Closed access
WSWen Shang Saw
Wen Shang Saw
TATheebaa Anasamy
Theebaa Anasamy
TDThu Thi Anh Do
Thu Thi Anh Do
HLHong Boon Lee
Hong Boon Lee
CCChin Fei Chee
Chin Fei Chee
LCLip Yong Chung
Lip Yong Chung

1 December 2017 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
SVSiew Hui Voon
Siew Hui Voon
CKChin Siang Kue
Chin Siang Kue
TIToyoko Imae
Toyoko Imae
WSWen Shang Saw
Wen Shang Saw
HLHong Boon Lee
Hong Boon Lee
SYShin-Ichi Yusa
Shin-Ichi Yusa